Bonjour Paris! World’s leading researchers and clinicians gather in Paris for largest MS conference

The MS Society of Canada’s research team has arrived in the exciting city of Paris, France to attend the 7th Joint ACTRIMS/ECTRIMS meeting from October 25-28, 2017. Paris tidbit: Jean Martin Charcot, who identified and named multiple sclerosis (la sclérose en plaques), is from Paris, France. The ACTRIMS/ECTRIMS Congress is the largest international meeting devoted to scientific research and health management of multiple sclerosis, and each year the list of topics and number of participants grows.

With over 9,000 participants from over 100 countries attending the meeting with a record number of abstracts at 2,080, the conference is bound to provide the latest information in research and clinical trial outcomes. Themes for this year’s meeting include the revised diagnostic criteria, biomarkers in MS, neuroimmunology, symptom management in MS, and emerging strategies to promote repair, just to name a few.  Selected abstracts will be presented throughout the week at poster sessions (researchers showcase their data on posters and engage in discussions) and scientific sessions (presentations that are delivered to a larger audience). The conference also includes smaller workshops and education sessions for nurses, junior neurologists in training, and media.

The conference is a great platform for announcing breaking news in MS research and treatment, and provides an opportunity for researchers, clinicians and trainees to share the hottest data from their laboratories.

This year the research team will be delivering live updates throughout the week via Twitter(@Dr_KarenLee), Facebook (Multiple Sclerosis Society of Canada), and my blog. We are excited to hear about the latest advances in MS and report it to our MS Community.

Stay tuned for more updates and feel free to leave questions or comments below.

Categories Research

National vice-president, research, past MS researcher, and PhD in Cellular and Molecular Medicine from University of Ottawa. Leads the MS Society's research program to find the cure for MS and improve the quality of life for people affected by the disease.

Leave a Reply

Your email address will not be published.